These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 38676580)
1. [Investigation of the Antibacterial Synergistic Activity of Fosfomycin-Teicoplanin Combination in Methicillin-Resistant Staphylococcus aureus Strains Isolated from Various Clinical Sample]. Biçer RT; Özekinci T; Koçoğlu ME Mikrobiyol Bul; 2024 Apr; 58(2):113-124. PubMed ID: 38676580 [TBL] [Abstract][Full Text] [Related]
2. In vitro activity of daptomycin combinations with rifampicin, gentamicin, fosfomycin and fusidic acid against MRSA strains. Aktas G; Derbentli S J Glob Antimicrob Resist; 2017 Sep; 10():223-227. PubMed ID: 28735049 [TBL] [Abstract][Full Text] [Related]
3. A study on combination of daptomycin with selected antimicrobial agents: in vitro synergistic effect of MIC value of 1 mg/L against MRSA strains. Lee YC; Chen PY; Wang JT; Chang SC BMC Pharmacol Toxicol; 2019 May; 20(1):25. PubMed ID: 31060599 [TBL] [Abstract][Full Text] [Related]
4. In vitro activity of two old antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus. Yu XH; Song XJ; Cai Y; Liang BB; Lin DF; Wang R J Antibiot (Tokyo); 2010 Nov; 63(11):657-9. PubMed ID: 20877368 [TBL] [Abstract][Full Text] [Related]
5. In vitro activity of fosfomycin in combination with linezolid against clinical isolates of methicillin-resistant Staphylococcus aureus. Xu-hong Y; Falagas ME; Dong W; Karageorgopoulos DE; De-feng L; Rui W J Antibiot (Tokyo); 2014 May; 67(5):369-71. PubMed ID: 24517925 [TBL] [Abstract][Full Text] [Related]
6. In vitro synergism of magnolol and honokiol in combination with antibacterial agents against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA). Zuo GY; Zhang XJ; Han J; Li YQ; Wang GC BMC Complement Altern Med; 2015 Dec; 15():425. PubMed ID: 26627468 [TBL] [Abstract][Full Text] [Related]
7. In vitro activity of minocycline combined with fosfomycin against clinical isolates of methicillin-resistant Staphylococcus aureus. Sun C; Falagas ME; Wang R; Karageorgopoulos DE; Yu X; Liu Y; Cai Y; Liang B; Song X; Liu Z J Antibiot (Tokyo); 2011 Aug; 64(8):559-62. PubMed ID: 21772306 [TBL] [Abstract][Full Text] [Related]
8. Synergism of coumarins from the Chinese drug Zanthoxylum nitidum with antibacterial agents against methicillin-resistant Staphylococcus aureus (MRSA). Zuo GY; Wang CJ; Han J; Li YQ; Wang GC Phytomedicine; 2016 Dec; 23(14):1814-1820. PubMed ID: 27912884 [TBL] [Abstract][Full Text] [Related]
9. In vitro activity of fosfomycin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy. Pistella E; Falcone M; Baiocchi P; Pompeo ME; Pierciaccante A; Penni A; Venditti M Infez Med; 2005 Jun; 13(2):97-102. PubMed ID: 16220029 [TBL] [Abstract][Full Text] [Related]
10. [Evaluation of In vitro Efficacy of Meropenem/Colistin and Meropenem/Fosfomycin Combinations on Multidrug Resistant Gram-Negative Bacilli]. Adaleti R; Nakipoğlu Y; Arıcı N; Kansak N; Çalık Ş; Şenbayrak S; Balık R; Aksaray S Mikrobiyol Bul; 2023 Jul; 57(3):365-377. PubMed ID: 37462301 [TBL] [Abstract][Full Text] [Related]
13. [Investigation of antibiotic resistance patterns and reduced vancomycin susceptibilities of methicillin-resistant Staphylococcus aureus isolates: a multi-center study]. Çıkman A; Aydın M; Gülhan B; Parlak M; Gültepe B; Kalaycı Y; Bayındır Bilmen F; Solmaz S; Özekinci T Mikrobiyol Bul; 2015 Apr; 49(2):240-8. PubMed ID: 26167824 [TBL] [Abstract][Full Text] [Related]
14. Susceptibility pattern of methicillin resistant Staphylococcus aureus to vancomycin and other alternate agents: report from a private sector hospital laboratory. Saleem F; Fasih N; Zafar A J Pak Med Assoc; 2017 Nov; 67(11):1743-1746. PubMed ID: 29171572 [TBL] [Abstract][Full Text] [Related]
15. In vitro antibacterial effects of Tanreqing injection combined with vancomycin or linezolid against methicillin-resistant Staphylococcus aureus. Yang W; Liu J; Blažeković B; Sun Y; Ma S; Ren C; Vladimir-Knežević S; Li C; Xing Y; Tian G; Wang Y BMC Complement Altern Med; 2018 May; 18(1):169. PubMed ID: 29848316 [TBL] [Abstract][Full Text] [Related]
16. In vitro activity of sodium new houttuyfonate alone and in combination with oxacillin or netilmicin against methicillin-resistant Staphylococcus aureus. Lu X; Yang X; Li X; Lu Y; Ren Z; Zhao L; Hu X; Jiang J; You X PLoS One; 2013; 8(7):e68053. PubMed ID: 23844154 [TBL] [Abstract][Full Text] [Related]
17. Staphylococcus aureus at an Indian tertiary hospital: Antimicrobial susceptibility and minimum inhibitory concentration (MIC) creep of antimicrobial agents. Khurana S; Mathur P; Malhotra R J Glob Antimicrob Resist; 2019 Jun; 17():98-102. PubMed ID: 30389637 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of Fosfomycin Resistance in Methicillin-Resistant Staphylococcus aureus Isolated from Patients in a University Hospital in China from 2013 to 2015. Wu D; Chen Y; Sun L; Qu T; Wang H; Yu Y Jpn J Infect Dis; 2018 Jul; 71(4):312-314. PubMed ID: 29709971 [TBL] [Abstract][Full Text] [Related]